• 
  Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, et al.. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial. Lancet Oncology, Elsevier, 2019, 20, pp.1740 - 1749. ⟨10.1016/S1470-2045(19)30486-3⟩. ⟨hal-03489049⟩
• 
  E. Rossignol, M.B. Amiand, J. Sorrieul, J.M. Bard, C. Bobin-Dubigeon. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics. Journal of Pharmacological and Toxicological Methods, Elsevier, 2020, 101, pp.106652 -. ⟨10.1016/j.vascn.2019.106652⟩. ⟨hal-03488936⟩
• 
  Hervé Bonnefoi, Gaetan Macgrogan, Coralie Poncet, Richard Iggo, Fanny Pommeret, et al.. Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. British Journal of Cancer, Cancer Research UK, 2019, 120 (9), pp.913-921. ⟨10.1038/s41416-019-0420-y⟩. ⟨hal-02282586⟩
• 
  Cecile Vicier, Patrick Sfumato, Nicolas Isambert, Florence Dalenc, Marie Robert, et al.. TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients. European Journal of Cancer, Elsevier, 2021, 159, pp.205 - 214. ⟨10.1016/j.ejca.2021.09.040⟩. ⟨inserm-03647613⟩
• 
  Jean-Michel Nguyen, Pascal Jézéquel, Pierre Gillois, Luisa Silva, Faouda Ben Azzouz, et al.. Random forest of perfect trees: concept, performance, applications and perspectives. Bioinformatics, Oxford University Press (OUP), 2021, 37 (15), pp.2165-2174. ⟨10.1093/bioinformatics/btab074⟩. ⟨inserm-03546813⟩
• 
  Gunjan Kayal, Maxime Chauvin, Alex Vergara Gil, Naomi Clayton, Ludovic Ferrer, et al.. Generation of clinical 177Lu SPECT/CT images based on Monte Carlo simulation with GATE. Physica Medica, Elsevier, 2021, 85 (4), pp.24-31. ⟨10.1016/j.ejmp.2021.04.002⟩. ⟨hal-03304053⟩
• 
  Marta Ferreira, Pierre Lovinfosse, Johanne Hermesse, Marjolein Decuypere, Caroline Rousseau, et al.. [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2021, 48 (11), pp.3432 - 3443. ⟨10.1007/s00259-021-05303-5⟩. ⟨inserm-03541325⟩
• 
  Pierre Peterlin, Joelle Gaschet, Thierry Guillaume, Alice Garnier, Marion Eveillard, et al.. A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia. Cancer Medicine, Wiley, 2021, 10 (2), pp.642-648. ⟨10.1002/cam4.3648⟩. ⟨inserm-03495750⟩
• 
  Appala Venkata Ramana Murthy, Vennu Narendar, Nangunoori Sampath Kumar, Pasula Aparna, Anagani Kanaka Durga Bhavani, et al.. Synthesis and biological studies of new piperidino-1,2,3-triazole hybrids with 3-aryl isoxazole side chains. Bioorganic & Medicinal Chemistry Letters, 2021, 52, pp.128390. ⟨10.1016/j.bmcl.2021.128390⟩. ⟨hal-03414697⟩
• 
  Julien Peron, Frédéric Mercier, Jean-Jacques Tuech, Rami Younan, Lucas Sideris, et al.. The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis. Surgery, Elsevier, 2019, 165 (2), pp.476-484. ⟨10.1016/j.surg.2018.07.027⟩. ⟨hal-02462757⟩
• 
  Gwenaelle Gravis, Jean-Marie Boher, Karim Fizazi, Florence Joly, Franck Priou, et al.. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model. European Urology, Elsevier, 2015, 68 (2), pp.196 - 204. ⟨10.1016/j.eururo.2014.09.022⟩. ⟨inserm-03353959⟩
• 
  Yohann Foucher, Marine Lorent, Philippe Tessier, Stéphane Supiot, Véronique Sébille, et al.. A Mini-Review of Quality of Life as an Outcome in Prostate Cancer Trials: Patient-Centered Approaches Are Needed to Propose Appropriate Treatments on Behalf of Patients. Health and Quality of Life Outcomes, 2018, 16 (1), pp.40. ⟨10.1186/s12955-018-0870-6⟩. ⟨hal-03158611⟩
• 
  Emmanuel Caruana, Yohann Foucher, Philippe Tessier, Jean-Sébastien Frenel, Jean-Marc Classe, et al.. Patient-Centered Simulations to Assess the Usefulness of the 70-Gene Signature for Adjuvant Chemotherapy Administration in Early-Stage Breast Cancer. Breast Cancer Research and Treatment, 2019, 174 (2), pp.537-542. ⟨10.1007/s10549-018-05107-6⟩. ⟨hal-03158776⟩
• 
  Pascal Jézéquel, Wilfried Gouraud, Fadoua Ben Azzouz, Catherine Guérin-Charbonnel, Philippe Juin, et al.. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database - The journal of Biological Databases and Curation, Oxford University Press, 2021, 2021, pp.baab007. ⟨10.1093/database/baab007⟩. ⟨inserm-03349355⟩
• 
  Marie-Mélanie Gac, Cécile Loaec, Johanna Silve, Edouard Vaucel, Paule Augereau, et al.. Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators. EJSO - European Journal of Surgical Oncology, WB Saunders, 2020, 47 (2), pp.360 - 366. ⟨10.1016/j.ejso.2020.08.003⟩. ⟨inserm-03349231⟩
• 
  Maximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, Marie-Gabrielle Dondon, Dorothée Le Gal, et al.. Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation. Breast Cancer Research, BioMed Central, 2021, 23 (1), ⟨10.1186/s13058-021-01456-1⟩. ⟨hal-03345365⟩
• 
  Fabienne Lesueur, Séverine Eon-Marchais, Sarah Bonnet-Boissinot, Juana Beauvallet, Marie-Gabrielle Dondon, et al.. TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing. Cancers, MDPI, 2021, 13 (15), pp.3659. ⟨10.3390/cancers13153659⟩. ⟨hal-03345372⟩
• 
  Gwenaelle Gravis, Jean-Marie Boher, Florence Joly, Michel Soulié, Laurence Albiges, et al.. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial. European Urology, Elsevier, 2016, 70, pp.256 - 262. ⟨10.1016/j.eururo.2015.11.005⟩. ⟨inserm-03343628⟩
• 
  Aurélien Corroyer-Dulmont, Cyril Jaudet, Anne-Marie Frelin, Jade Fantin, Kathleen Weyts, et al.. Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice. Frontiers in Oncology, Frontiers, 2021, 11, pp.714514. ⟨10.3389/fonc.2021.714514⟩. ⟨hal-03335353⟩
• 
  Florence Joly, Claudia Lefeuvre-Plesse, Claire Garnier-Tixidre, Carole Helissey, Nathalie Menneveau, et al.. Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trial. BMC Cancer, BioMed Central, 2020, 20 (1), ⟨10.1186/s12885-020-07381-4⟩. ⟨hal-03334144⟩

68